The Oncology Institute, Inc.
The Oncology Institute, Inc.（TOI）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · TOI · 截至 2025年9月30日
股东结构概览
114
机构持有人数
▲ 35 vs Q2
$120.99M
机构持仓总市值
▲ $55.52M vs Q2
99.98M
总流通股
freeFloat 49.41%
34.67M
13F 申报持股数
▲ 2.73M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
TOI 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC services-offices & clinics of doctors of medicine | 4.55M | 48.77% | 48.77% | $15.86B | Nov 7, 2025 | ▲ 264.4K |
BLACKROCK, INC. services-offices & clinics of doctors of medicine | 3.43M | 36.85% | 36.85% | $11.99B | Nov 12, 2025 | ▲ 128.0K |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) services-offices & clinics of doctors of medicine | 3.36M | 36.05% | 36.05% | $11.73B | Nov 14, 2025 | — held |
CENTERBOOK PARTNERS LP services-offices & clinics of doctors of medicine | 2.70M | 29.02% | 29.02% | $9.44B | Nov 7, 2025 | ▲ 1.99M |
BALYASNY ASSET MANAGEMENT L.P. services-offices & clinics of doctors of medicine | 2.52M | 27.02% | 27.02% | $8.79B | Nov 14, 2025 | — held |
KANEN WEALTH MANAGEMENT LLC services-offices & clinics of doctors of medicine | 1.84M | 19.76% | 19.76% | $6.42B | Nov 14, 2025 | NEW |
WEXFORD CAPITAL LP services-offices & clinics of doctors of medicine | 1.57M | 16.86% | 16.86% | $5.48B | Nov 14, 2025 | ▲ 452.4K |
GEODE CAPITAL MANAGEMENT, LLC services-offices & clinics of doctors of medicine | 1.40M | 15.04% | 15.04% | $4.89B | Nov 12, 2025 | ▲ 122.5K |
STATE STREET CORP services-offices & clinics of doctors of medicine | 1.13M | 12.12% | 12.12% | $3.94B | Nov 14, 2025 | ▲ 483.8K |
UBS GROUP AG services-offices & clinics of doctors of medicine | 1.06M | 11.33% | 11.33% | $3.68B | Nov 13, 2025 | ▲ 635.5K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
20
增持
+6.61M 股14
新建仓
首次建仓9
减持
−5.42M 股0
清仓
完全退出净股数变化（前50家）
+1.19M
+6.61M / −5.42M
净新增持仓人
+25
新建 14 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
TOI 内幕交易记录
数据来源：SEC Form 4
近期内部人员净买入。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
5
买入笔数
5
卖出笔数
1.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Chernett Jorey 10 percent owner | Jun 4, 2026 | Purchase | 12,000 | $4.75 | $57.0K | 10.58M | Form 4 ↗ |
Podnos Yale Chief Medical Officer | May 21, 2026 | J-Other | 1,805 | $4.47 | $8.1K | 283.0K | Form 4 ↗ |
Virnich Daniel Chief Executive Officer | May 21, 2026 | J-Other | 23,058 | $4.47 | $103.1K | 2.34M | Form 4 ↗ |
Carter Robert Ross Chief Financial Officer | May 21, 2026 | J-Other | 1,604 | $4.47 | $7.2K | 414.8K | Form 4 ↗ |
Chernett Jorey 10 percent owner | May 20, 2026 | Purchase | 33,500 | $4.07 | $136.3K | 10.57M | Form 4 ↗ |
Chernett Jorey 10 percent owner | May 19, 2026 | Purchase | 5,000 | $4.05 | $20.3K | 10.53M | Form 4 ↗ |
Chernett Jorey 10 percent owner | May 19, 2026 | Purchase | 30,000 | $4.09 | $122.7K | 10.53M | Form 4 ↗ |
Kaushal Mohit director | Apr 14, 2026 | Sale | 57,286 | $3.50 | $200.6K | 211.0K | Form 4 ↗ |
Kaushal Mohit director | Apr 16, 2026 | Sale | 38,433 | $3.50 | $134.5K | 172.6K | Form 4 ↗ |
Chernett Jorey 10 percent owner | Apr 9, 2026 | Purchase | 20,000 | $3.10 | $62.0K | 10.50M | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
The Oncology Institute, Inc.（TOI）主要由机构投资者持有，机构持股比例约为 34.7%。公司内部人员持股约 50.59%，散户及公众持股约占剩余的 14.73%。
The Oncology Institute, Inc. 最大机构股东为 VANGUARD GROUP INC，截至 September 30, 2025 持有约 4.55 million 股，占总流通股的 48.77%。
目前共有 114 家机构持有 TOI 股票，合计持仓市值约 $120,993,806，数据来源为最新 SEC 13F 申报。
常见问题
TOI ownershipThe Oncology Institute, Inc.（TOI）主要由机构投资者持有，机构持股约 34.7%。最大股东为 VANGUARD GROUP INC，持股比例 48.77%。内部人员持股约 50.59%。数据来源 SEC Form 13F，截至 September 30, 2025。